Form 8.3 - AON PLC

Form 8.3 - AON PLC

BARCLAYS PLC

 

Ap19

FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1. KEY INFORMATION

Name of person dealing (Note 1) Barclays PLC.
Company dealt in AON PLC
Class of relevant security to which the ORD
dealings being disclosed relate (Note 2)
Date of dealing 07 April 2021

2. INTERESTS AND SHORT POSITIONS

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

Class of relevant security: ORD
Long Short
Number (%) Number (%)

(1)

Relevant securities

456,046

0.20%

1,753,440

0.78%

 

 

 

 

(2)

Derivatives (other than options):

 

 

 

 

95,497

0.04%

13,691

0.01%

 

 

 

 

(3)

Options and agreements to

 

 

 

 

purchase/sell:

24,200

0.01%

24,200

0.01%

 

 

 

 

TOTAL:

 

 

 

 

575,743

0.25%

1,791,331

0.79%

 

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security:

Long

Short

 

Number

 

(%)

Number

 

(%)

(1) Relevant securities

 

 

 

(2) Derivatives (other than options)

 

 

 

(3) Options and agreements to purchase/sell

 

 

Total

 

 

 

Ap20

1. DEALINGS (Note 4)

(a) Purchases and sales

Purchase/sale Number of relevant securities Price per unit

Purchase

1

236.3800 USD

Purchase

5

234.3860 USD

Purchase

5

235.3480 USD

Purchase

33

236.3300 USD

Purchase

50

236.1100 USD

Purchase

100

236.3000 USD

Purchase

101

236.1554 USD

Purchase

134

236.0318 USD

Purchase

200

234.5001 USD

Purchase

200

235.2250 USD

Purchase

206

236.0953 USD

Purchase

218

236.1246 USD

Purchase

276

236.1200 USD

Purchase

293

236.1089 USD

Purchase

513

236.1508 USD

Purchase

1,180

236.1310 USD

Purchase

1,203

236.0901 USD

Purchase

1,300

235.2130 USD

Purchase

1,310

235.0732 USD

Purchase

1,913

236.0801 USD

Purchase

4,592

235.4584 USD

Purchase

4,851

236.1156 USD

Purchase

4,993

235.9576 USD

Purchase

6,083

235.7266 USD

Purchase

10,451

236.2700 USD

Purchase

10,753

235.8926 USD

Purchase

10,800

236.2947 USD

Purchase

18,994

235.0468 USD

Purchase

33,814

235.9642 USD

Sale

1

234.5500 USD

Sale

1

234.3600 USD

Sale

3

234.3400 USD

Sale

24

236.3800 USD

Sale

100

236.1300 USD

Sale

107

236.2552 USD

Sale

127

236.2933 USD

Sale

134

236.0318 USD

Sale

200

234.5001 USD

Sale

200

235.6250 USD

Sale

200

236.2250 USD

Sale

200

235.3300 USD

Sale

200

235.2200 USD

Sale

208

235.5514 USD

Sale

216

235.1751 USD

Sale

250

236.2520 USD

Sale

259

236.2098 USD

Sale

291

235.1424 USD

Sale

300

234.7833 USD

Sale

320

235.1487 USD

Sale

337

236.1948 USD

Sale

374

235.9214 USD

Sale

400

235.9350 USD

Sale

411

235.6074 USD

Sale

437

236.2409 USD

Sale

500

236.1890 USD

Sale

500

236.1140 USD

Sale

516

235.6348 USD

Sale

546

236.2734 USD

Sale

563

236.2038 USD

Sale

594

236.3206 USD

Sale

1,385

236.2797 USD

Sale

1,430

235.8714 USD

Sale

1,565

236.1259 USD

Sale

1,658

236.2940 USD

Sale

2,547

236.0697 USD

Sale

2,583

236.2867 USD

Sale

3,026

235.9939 USD

Sale

3,089

235.6200 USD

Sale

3,633

236.3132 USD

Sale

4,802

235.7392 USD

Sale

5,803

236.1043 USD

Sale

6,089

235.8218 USD

Sale

6,159

235.9827 USD

Sale

6,171

235.9063 USD

Sale

8,339

235.2790 USD

Sale

10,416

236.2700 USD

Sale

13,498

234.9277 USD

Sale

25,378

235.9826 USD

(b) Derivatives transactions (other than options transactions)

Product name,

e.g. CFD

Nature of transaction

(Note 6)

Number of relevant securities

(Note 7)

Price per unit

(Note 5)

 

 

 

 

(c) Options transactions in respect of existing relevant securities

(i) Writing, selling, purchasing or varying

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 5)

 

 

 

 

 

 

 

(ii) Exercising

Product name,

e.g. call option

Number of securities

Exercise price per unit (Note 5)

 

 

 

(d) Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction

(Note 8)

Details

Price per unit

(if applicable) (Note 5)

 

 

 

 

Ap21

2. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

None

Is a Supplemental Form 8 (Open Positions) attached? YES
Date of disclosure:

8 Apr 2021

Contact name:

Large Holdings Regulatory Operations

Telephone number:

020 3134 7213

If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection

Ap23

SUPPLEMENTAL FORM 8

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DETAILS OF OPEN POSITIONS

(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)

OPEN POSITIONS (Note 1)

Product name Written or Number of Exercise Type Expiry
purchased relevant securities price date
to which the option
or derivative
relates

Put Options

Purchased

-1,200

220.0000

American

Jul 16, 2021

Call Options

Purchased

1,200

240.0000

American

Jul 16, 2021

Call Options

Purchased

23,000

220.0000

American

Jul 16, 2021

Put Options

Purchased

-23,000

200.0000

American

Jul 16, 2021

Notes

1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.

2. For all prices and other monetary amounts, the currency must be stated.

For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.

UK 100

Latest directors dealings